Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Current Standards of Care and Long Term Outcomes for Thalassemia and Sickle Cell Disease.

Advances in experimental medicine and biology - 1 Jan 2017

Chonat Satheesh, Quinn Charles T

Abstract excerpt

Thalassemia and sickle cell disease (SCD) are disorders of hemoglobin that affect millions of people worldwide. The carrier states for these diseases arose as common, balanced polymorphisms during human history because they afforded protection against severe forms of malaria. These complex, multisystem diseases are reviewed here with a focus on current standards of clinical management and recent research...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anemia, Sickle Cell
Share to beta-Globins
Share to Malaria

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Outcome Assessment, Health Care

Share to Survival Analysis

Share to Thalassemia

Share to Time Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 29127677
DOI: 10.1007/978-1-4939-7299-9_3
PMCID: PMC5720159

Genes

SCD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Current Standards of Care and Long Term Outcomes for Thalassemia and Sickle Cell Disease.PMID 29127677Read ↗

Sickle Cell Disease.Semantic proximity Read ↗

Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panelSemantic proximity Read ↗

Current and emerging treatments for sickle cell diseaseSemantic proximity Read ↗

Updated Worldwide Epidemiology of Inherited Erythrocyte DisordersSemantic proximity Read ↗

Definitions of the phenotypic manifestations of sickle cell disease.Semantic proximity Read ↗

Sickle Cell DiseaseSemantic proximity Read ↗

Clinical Classification, Screening and Diagnosis for Thalassemia.Semantic proximity Read ↗

Biomarkers and recent advances in the management and therapy of sickle cell diseaseSemantic proximity Read ↗

Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical ManagementSemantic proximity Read ↗

Sickle Cell DiseaseSemantic proximity Read ↗

Disease burden, management strategies, and unmet needs in α-thalassemia due to hemoglobin H disease.Semantic proximity Read ↗

Management of Sickle Cell DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.